SCHEMBL7030775

SCHEMBL7030775

Cc1cc2c(cc1Cl)CCC(=O)O2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH2 P05091 1/20 0.53
ALDH3A1 P30838 1/20 0.53
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPT P10636 3/20 0.44
ALDH1A1 P00352 2/20 0.44
THRB P10828 1/20 0.44
ALOX12 P18054 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
TSHR P16473 1/20 0.34
MAOB P27338 1/20 0.33
CD44 P16070 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6836680 0.85 ALDH2 (0.58) ALDH2ALDH3A1MEN1KMT2AMAPT
SCHEMBL6832877 0.77 ALDH2 (0.51) ALDH2ALDH3A1TSHRMAOB
SCHEMBL14192627 0.76 ALDH2 (0.51) ALDH2ALDH3A1TSHRMAOB
SCHEMBL13673041 0.76 ALDH2 (0.50) ALDH2ALDH3A1MEN1KMT2AMAPT
SCHEMBL13389081 0.75 ALDH2 (0.53) ALDH2ALDH3A1MEN1KMT2AMAPT
SCHEMBL6832714 0.74 ALDH2 (0.51) ALDH2ALDH3A1TSHRMAOB
SCHEMBL15354652 0.72 ALDH2 (0.50) ALDH2ALDH3A1MEN1KMT2AMAPT
SCHEMBL27762658 0.72 MEN1 (0.32) MEN1KMT2AMAPTALOX12TDP1
SCHEMBL13708741 0.72 FABP4 (0.38) MAPTALDH1A1CD44
SCHEMBL5799941 0.70 ALDH2 (0.47) ALDH2ALDH3A1ALDH1A1TSHRMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102161653-A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof ABBOTT LAB 2011-08-24 CN disclosed
CN-101443327-A Chromanylurea compounds that inhibit vanilloid receptor subtype 1(VR1) receptor and uses thereof ABBOTT LAB (US) 2009-05-27 CN disclosed
EP-1322308-A2 DEVICES AND METHODS FOR MANAGEMENT OF INFLAMMATION Durect Corporation (US) 2003-07-02 EP disclosed
WO-2002028366-A9 DEVICES AND METHODS FOR MANAGEMENT OF INFLAMMATION DURECT CORP (US) 2003-02-13 WO disclosed
WO-2002028366-A2 DEVICES AND METHODS FOR MANAGEMENT OF INFLAMMATION DURECT CORPORATION (US) 2002-04-11 WO disclosed